Market Research Logo

Indonesia Pharmaceuticals & Healthcare Q2 2018

BMI Industry View
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Healthcare Market Forecast
Prescription Drug Market Forecast
Patented Drug Market Forecast
Generic Drug Market Forecast
OTC Medicine Market Forecast
Pharmaceutical Trade Forecast
Industry Risk/Reward Index
Asia Pacific Pharmaceuticals: Region Characterised By A Mix Of Risks And Rewards
Regulatory Development
Regulatory Review
Industry Trends And Developments
Market Overview
Competitive Landscape
Company Profile
Bayer
Darya-Varia Group
GlaxoSmithKline
Indofarma
Kimia Farma
Merck & Co
Merck Group
Novartis
Pfizer
PT Bio Farma
PT Kalbe Farma
Sanofi
Soho Global Healthcare Group
Demographic Forecast
Demographic Outlook
Pharmaceuticals & Healthcare Glossary
Methodology

Indonesia Pharmaceuticals & Healthcare Q2 2018

BMI View:

Although the political situation remains unsettled, we continue to view Indonesian pharmaceutical andhealthcare markets as having strong commercial potential, especially in the longer term. The country's large and rapidly growingpopulation underpin this view, although the success of the involvement in the sector remain at risk from the lacking intellectualproperty environment and also the authorities' efforts to promote domestic pharmaceutical manufacturing and thus reducereliance on imports.


Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report

;